US20070116593A1 - Occult blood testing apparatus with features for enhancing ease of use - Google Patents
Occult blood testing apparatus with features for enhancing ease of use Download PDFInfo
- Publication number
- US20070116593A1 US20070116593A1 US11/654,067 US65406707A US2007116593A1 US 20070116593 A1 US20070116593 A1 US 20070116593A1 US 65406707 A US65406707 A US 65406707A US 2007116593 A1 US2007116593 A1 US 2007116593A1
- Authority
- US
- United States
- Prior art keywords
- specimen
- housing
- applicator
- test matrix
- placement area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 60
- 239000008280 blood Substances 0.000 title abstract description 14
- 210000004369 blood Anatomy 0.000 title abstract description 14
- 230000002708 enhancing effect Effects 0.000 title abstract description 3
- 239000011159 matrix material Substances 0.000 claims abstract description 39
- 238000003892 spreading Methods 0.000 claims abstract description 13
- 210000003811 finger Anatomy 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 7
- 230000002547 anomalous effect Effects 0.000 claims description 4
- 210000003813 thumb Anatomy 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims 3
- 238000010168 coupling process Methods 0.000 claims 3
- 238000005859 coupling reaction Methods 0.000 claims 3
- 230000013011 mating Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 238000012956 testing procedure Methods 0.000 abstract description 3
- 230000002550 fecal effect Effects 0.000 description 10
- 210000003608 fece Anatomy 0.000 description 10
- 239000003708 ampul Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 241000147041 Guaiacum officinale Species 0.000 description 3
- 229940091561 guaiac Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 239000012916 chromogenic reagent Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0038—Devices for taking faeces samples; Faecal examination devices
Definitions
- the present invention is directed to systems and methods useful in testing for occult blood in a fecal specimen. More particularly, the invention is directed to a testing apparatus which is suitable for at-home use by untrained individuals, as well as by clinicians in hospitals and doctor offices.
- Conventional screening procedures consist of testing for occult (hidden) blood in stool samples provided by a patient.
- the patient must collect two separate specimens on a test card on each of three consecutive days, and then deliver the test cards to a laboratory.
- a physician or lab technician applies developer liquid to each specimen's test matrix, which has previously been impregnated with a suitable chromogenic reagent, such as guaiac. If blood is present in the specimen, the chromogenic reagent will cause the test matrix to change colors when the developer fluid is added, indicating that fecal occult blood or a similar reactant has been found.
- the Diagnostica kit comprises a container of free-standing developing medium, and a test matrix having a specimen placement area on one side. On the opposite side of the test matrix is a result area that generally coincides with the specimen placement area, and a control area that is longitudinally spaced from the result area.
- Both the container and the matrix are encased in a housing having a first pair of openings aligned with the specimen placement area, a second pair of openings aligned with the result area, and a third pair of openings aligned with the control area.
- a cover is provided for securely enclosing a specimen located on the specimen placement area. To test for occult blood, a user simply places fecal specimens in the openings aligned with the specimen placement area, closes the cover, compresses the housing to break the container and releases the developing medium. He or she then turns the housing over to look for appropriate color changes in the result and control areas.
- the aforementioned Diagnostica test kit possesses numerous advantages over the prior art.
- the cover is particularly advantageous, since it keeps the fecal specimen out of the user's sight and prevents it from dropping off of leaking from the specimen placement area, even when the user inverts the housing to read the results.
- the kit can be disposed of easily and hygienically after testing, with no need for special handling.
- the Diagnostica kit disclosed in the aforementioned U.S. and International patent applications has some potential drawbacks. Users who have not performed the test before may have difficulty understanding or remembering the instructions and may perform the steps in the wrong order. In addition, some users may collect too little or too much sample on the stick provided with the kit, and have difficulty spreading it over the specimen placement area. Still others may find it difficult to open and close the cover of the housing with one hand while holding the specimen collection stick in the other hand.
- a self-contained system for testing for the presence of occult blood in a specimen has been provided with features enhancing its ease of use.
- the system includes a housing holding a test matrix and a container for releasing a developing medium onto the test matrix.
- the housing includes a base portion encasing both the container and the test matrix, and a moveable cover for selectively covering and uncovering the base.
- the cover is provided with a tab which can be manipulated with a finger of one hand, and the base is provided with tabs which can be grasped easily with one or two other fingers of the same hand, thus allowing the cover to be easily opened and closed with one hand.
- An applicator provided for use with the system includes a handle portion configured to be grasped by a user and a distal portion having an end configured for optimized retrieval and spreading of the specimen on the test matrix.
- the applicator comprises two identical applicator halves, one of which serves as the handle portion and the other of which serves as the distal portion. Connector elements are provided for joining the two halves together.
- the two halves are integrally formed with and frangibly connected to opposite sides of the system housing. To use the applicator, a user simply detaches the two applicator halves from the housing, assembles them end-to-end, then collects and applies the specimen as instructed.
- the instructions for use are preferably embossed or otherwise printed on the various components of the system. These instructions preferably indicate both the order in which the steps of the testing procedure are to be performed, and the location for carrying out the steps.
- steps to be performed with the cover closed are provided on the cover
- steps to be performed with the cover open are provided on the top portion of the base
- steps to be performed with the housing inverted (and the cover closed) are provided on the bottom portion of the base.
- FIG. 1 is a perspective view of a system for testing for fecal occult blood in accordance with the present invention, with a portion broken away to show interior detail;
- FIG. 2 is a plan view of the housing, cover, and applicator of the system before assembly;
- FIG. 2A is an enlarged end view of the bottom section of the housing before assembly
- FIG. 3 is a plan view of the system after assembly
- FIG. 4 is an enlarged fragmentary perspective view showing a portion of the base of the system housing, with a portion broken away to show interior detail;
- FIG. 5 is a perspective view of an applicator assembly in accordance with the present invention.
- FIG. 6 is an enlarged plan view of the encircled area 6 - 6 of FIG. 5 ;
- FIG. 7 is a plan view of the encircled area 7 - 7 of FIG. 5 ;
- FIG. 8 is an enlarged, fragmentary view of a section taken through line 8 - 8 of FIG. 1 ;
- FIG. 9 is an enlarged end view of FIG. 7 ;
- FIG. 10 is a top plan view of the housing of the system according to a preferred embodiment, with the cover in a closed position;
- FIG. 11 is a perspective view of the housing according to the embodiment shown in FIG. 10 , with the cover in an open position;
- FIG. 12 is a bottom plan view of the housing according to the embodiment of FIG. 10 .
- FIG. 1 shows a self-contained system 10 for testing for a reactant such as occult blood in a specimen of a spreadable substance such as fecal matter (not shown).
- the system comprises a housing 12 enclosing a test matrix 14 such as guaiac-treated paper (shown in FIG. 4 ), and a glass ampule 16 filled with a free-standing liquid developing medium such as liquid hydrogen peroxide/ethyl alcohol solution.
- An applicator 18 is provided for collecting the fecal matter specimen and applying it to a specimen placement area 20 on the test matrix 14 .
- the unassembled housing which is preferably provided to the consumer in a hermetically sealed foil pouch (not shown), includes a base 22 and a cover 24 .
- the base 22 has a bottom section 26 and a top section 28 .
- Identical applicator halves 30 and 32 are coupled to opposite sides of the top section 28 of the base 22 .
- the cover 24 , bottom section 26 , top section 28 , and applicator halves 30 , 32 are made from a unitary or single piece of plastic or polymer material.
- the cover 24 , bottom base section 26 , and top base section 28 are preferably flexibly and serially joined to one another by thinned hinge elements 34 and 36 , while the applicator halves 30 , 32 are frangibly connected to the top section 28 of the base 22 by weakened elements 38 , 39 , 40 , and 41 .
- Other embodiments of the invention may provide the applicator separately from the housing, for example, and/or in a single piece, as a pair of non-identical pieces or more than two pieces.
- the cover and the sections of the base could be made of more than one piece, made of materials other than plastic, and/or have sections of other shapes.
- FIG. 3 shows the system 10 in the form in which it is provided to the user.
- the test matrix and ampule have been placed underneath the top section 28 of the base 22 , and the bottom section 26 has been folded up against the top section 28 , locking the test matrix and ampule into position.
- the cover 24 has been latched over the specimen placement openings to prevent contamination of the test matrix during transport.
- the only portion of the system 10 which has not been preassembled is the applicator 18 .
- the bottom section 26 of the base 22 has two oblong openings 42 , 44 near a first end 46 .
- the oblong openings have beveled edges 48 for better viewing of the validation areas 50 of the test matrix 14 .
- Two rectangular openings 52 , 54 are provided near a second end 56 of the bottom section 26 .
- the rectangular openings 52 , 54 have beveled edges 58 for better viewing of the result areas 60 of the test matrix 14 .
- a circular depression 62 is located in the second surface 51 intermediate the validation area viewing openings 42 , 44 and the result area viewing openings 52 , 54 .
- a protuberance 64 is located in the center of the depression 62 .
- the depression 62 decreases the rigidity of the bottom section 26 and enables a user to compress the ampule when the protuberance 64 is pressed against a hard, flat surface such as a table or counter top.
- a depression 62 formed in the second surface 51 of the bottom section 26 reduces the amount of liquid needed to saturate the matrix relative to the amount that would be needed if the depression were formed in the first surface 49 .
- FIG. 2A is an enlarged end view showing that the bottom section 26 of the base is slightly curved about a vertical axis of symmetry y.
- the bottom section 26 has generally flat side edge portions 43 , 45 , and a central portion 47 including a first surface 49 and a second surface 51 , both of which are somewhat concave with respect to the illustrated horizontal axis x.
- the curvature is flattened with respect to the horizontal axis x.
- the first surface 49 is urged against the center of the top section, compressing the test matrix and holding it securely in place. This minimizes the amount of open space between the top and bottom sections 26 and 28 , which in turn further minimizes the amount of liquid needed to saturate the matrix in a given short period of time.
- the top section 28 of the base 22 includes two rectangular openings 66 , 68 that align with specimen placement areas 70 on the text matrix 14 , on the opposite side from the result areas 60 and result viewing openings 52 , 54 .
- An oblong ampule-holding dome 74 extends between the specimen placement openings 66 , 68 and the end of the top section 28 near the rear hinge 34 . Extending from the inner top wall of the dome 74 are two projections (not shown) which act in tandem with the depression 62 and protuberance 64 on the bottom section 26 to facilitate breaking of the ampule 16 .
- the front hinge 36 projects distally along the front of the section 28 and matingly receives a hook 75 depending from the underside of the cover 24 to latch the cover when necessary.
- a gripping arrangement comprising tabs 77 , 79 and 81 (seen in FIG. 10 ) is provided for allowing a user to easily open and close the cover 24 with one hand while holding an applicator in the other hand.
- the tabs 77 , 79 which extend distally and laterally from the corners of the top section 28 on either side of the hinge 36 , are structured for a user to hold between two fingers, for instance the thumb and middle finger, of one hand while pressing upwardly with another finger, for instance the index finger, of the same hand against the tab 81 extending distally from the front edge of the cover 24 .
- only one tab 77 or 79 is required on the top section 28 of the base, since most users will be able to open the cover 24 using only the thumb and finger of one hand.
- two tabs 77 , 79 are preferred, since such an arrangement is equally convenient for both right and left-handed users, and also for users with decreased manual dexterity or strength.
- each of the applicator halves 30 , 32 comprises a relatively narrow distal end 76 a,b and a wider, hollow proximal end 78 a,b .
- the user simply detaches the two applicator halves 30 , 32 from the sides of the base 28 , and inserts the distal end 76 b of one applicator half 32 into the hollow proximal end 78 a of the other applicator half 30 .
- a close fit between the distal end 76 b of one applicator half 32 and the receiving proximal end 78 a of the other applicator half 30 ensures that the halves 30 , 32 will be securely joined.
- the proximally positioned half 32 serves as a handle to be grasped by the user, while the distal end 76 a of the distally positioned half 30 serves as a collector and spreader.
- the spreader or distal end 76 a of the applicator 18 includes a generally planar front surface 80 , a generally planar rear surface (not shown) and a pair of side walls 82 , 84 .
- the front and rear surfaces are recessed with respect to the side walls 82 , 84 , and intersect to form a shoulder 86 that curves about a center of curvature x′ to define a first radius of curvature R.
- a spreading tip 88 extends distally of the shoulder 86 .
- the specimen placement openings 66 , 68 have beveled, generally trapezoidal walls 72 that assist in positioning specimens on the specimen placement area 70 and define a recess with enough volume to receive and hold a fecal sample when the cover 24 is closed.
- Each recess has a width w equal to the width of the specimen placement area and a depth d equal to the height of the beveled walls 72 .
- the spreading tip 88 includes a pair of side edges 92 , 93 which are preferably conical and have a cone angle conforming to the beveled side walls 72 of the specimen placement openings 66 , 68 .
- the width w of the distal surface 90 is substantially equal to the width w of the specimen placement openings 66 , 68
- the length L of the spreading tip 88 is slightly less than the depth d of the specimen placement openings 66 , 68 . This close fit between the tip 88 and the specimen placement openings 66 , 68 helps ensure that the applicator tip spreads the specimen evenly and thinly over the specimen placement area.
- the spreading tip has a curved distal surface 90 that extends between the side edges 92 , 93 .
- the distal and proximal surfaces 90 , 91 of the spreading tip 88 are preferably textured or otherwise enhanced to increase the amount of fecal matter collected by the applicator 18 and minimize the likelihood of any fecal matter falling off.
- the textured surface 90 comprises a multitude of small bumps yielding a sandpaper-like finish.
- Other surface features, such as grooves, fins, dimples or the like, that increase the effective surface area and holding power of the tip can also be used.
- the retentiveness of the surface could be enhanced with coatings having adhesive properties or an affinity for fecal matter.
- FIGS. 10-12 show an especially preferred embodiment of the invention, wherein the various components of the housing 12 include indicia leading the user through the steps of a testing procedure.
- the indicia are preferably provided in sets, with each set of indicia designating both the order in which a particular step is to be performed, and the place for performing it.
- a first set of indicia 94 provided near the distal end of the cover 24 of the housing 12 may point toward the tab 81 and instruct the user to “ LIFT FIRST .”
- the user may find a second set of indicia 95 near the specimen placement openings 66 , 68 , instructing him or her to (apply the) “ SAMPLES 2 nd .”
- a third set of indicia 96 located on the cover 24 on an upper dome 97 above the ampule-holding dome 74 may instruct the user to “ PRESS 3 rd ”, thus breaking the capsule and releasing the developing medium onto the test matrix.
- a fourth set of indicia 98 on the bottom section 26 of the housing base 22 identifies the location of the “ CONTROLS ” and “ RESULTS ” and instructs the user that these are to be viewed “4 th .”
- the indicia be embossed on the housing.
- imprinted stickers or other less permanent forms of indicia may be preferable in some instances, especially in overseas markets where many languages will be required.
- Additional indicia could be provided for designating where to snap the applicator halves off the housing, indicating which end of the applicator is the sample end, warning the user not to open the base because of glass inside, and so forth.
- the exact wording of any of the instructions is not critical, and may be varied according to consumer needs.
- the indicia may also provide information such as a website, mailing address, or phone number which the user may contact if he or she has questions about the procedure or results. If the results are positive or indeterminate, the user may wish to save another undeveloped test kit to show to a physician. Ideally, if the results are clearly negative, the user simply reinserts the kit and applicator halves into the foil pouch in which they were provided, folds over the top of the pouch, and throws it away. No further special handling or sanitary precautions are needed since the fecal matter is entirely enclosed.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
- This is a divisional of U.S. patent application Ser. No. 10/139,473 filed on May 3, 2002, the entire disclosure of which is incorporated herein.
- The present invention is directed to systems and methods useful in testing for occult blood in a fecal specimen. More particularly, the invention is directed to a testing apparatus which is suitable for at-home use by untrained individuals, as well as by clinicians in hospitals and doctor offices.
- Over 140,000 new persons per year in the United States are afflicted with cancer of the colon and rectum, the disease occurring equally in both men and women. Contrary to many other forms of cancer, early diagnosis and treatment of colorectal cancer and its precursor polyps does result in a cure rate of 80% to 90%. If, however, the disease is not detected until the later stages, the cure rate drops significantly. Thus, early detection of the disease is important to successful treatment of colorectal cancer. For this reason, it is recommended that all individuals over
age 50 with no family history of the disease be screened annually for colorectal cancers. Individuals with family history of the disease or other known risk factors should be screened annually beginning no later thanage 40. - Conventional screening procedures consist of testing for occult (hidden) blood in stool samples provided by a patient. Typically, the patient must collect two separate specimens on a test card on each of three consecutive days, and then deliver the test cards to a laboratory. At the laboratory, a physician or lab technician applies developer liquid to each specimen's test matrix, which has previously been impregnated with a suitable chromogenic reagent, such as guaiac. If blood is present in the specimen, the chromogenic reagent will cause the test matrix to change colors when the developer fluid is added, indicating that fecal occult blood or a similar reactant has been found.
- One factor deterring individuals from undergoing their recommended annual screening is the natural revulsion which many, if not most, people feel toward handling and looking at fecal matter. This revulsion may be amplified by the lack of a suitable implement for obtaining a specimen and applying it to the test matrix. Most test kits simply provide a wooden coffee-stirrer type stick which is somewhat difficult to manipulate and often, because of its generally smooth exterior surface, does not pick up a large enough sample or retain the sample without risk of dropping some of the fecal matter. Another unpleasant factor is the inconvenience and, sometimes, embarrassment associated with transporting or mailing the fecal matter specimens to a testing laboratory in a paper envelope.
- In order to eliminate or reduce the aforementioned problems, various attempts have been made to develop a convenient test kit which requires a minimum of handling of fecal specimens, and can be performed by an untrained individual in the privacy of his or her own home. Examples of such attempts are disclosed in U.S. Pat. Nos. 4,582,685 and 5,196,167 to Guadagno et al., and U.S. Pat. No. 5,840,584 to Waldenburg. None of these prior art test kits have successfully met all of the needs of in-home users, however, and none has been approved by the FDA for over-the-counter sale.
- To date, the only fecal occult blood testing kit which has been approved by for the FDA for over-the-counter sale is a kit manufactured by Diagnostica, Inc., of Las Vegas, Nev., features of which are disclosed in U.S. patent application Ser. No. 09/132,439 and International Application No. PCT/US99/17954. The Diagnostica kit comprises a container of free-standing developing medium, and a test matrix having a specimen placement area on one side. On the opposite side of the test matrix is a result area that generally coincides with the specimen placement area, and a control area that is longitudinally spaced from the result area. Both the container and the matrix are encased in a housing having a first pair of openings aligned with the specimen placement area, a second pair of openings aligned with the result area, and a third pair of openings aligned with the control area. A cover is provided for securely enclosing a specimen located on the specimen placement area. To test for occult blood, a user simply places fecal specimens in the openings aligned with the specimen placement area, closes the cover, compresses the housing to break the container and releases the developing medium. He or she then turns the housing over to look for appropriate color changes in the result and control areas.
- The aforementioned Diagnostica test kit possesses numerous advantages over the prior art. The cover is particularly advantageous, since it keeps the fecal specimen out of the user's sight and prevents it from dropping off of leaking from the specimen placement area, even when the user inverts the housing to read the results. In addition, the kit can be disposed of easily and hygienically after testing, with no need for special handling.
- Nonetheless, the Diagnostica kit disclosed in the aforementioned U.S. and International patent applications has some potential drawbacks. Users who have not performed the test before may have difficulty understanding or remembering the instructions and may perform the steps in the wrong order. In addition, some users may collect too little or too much sample on the stick provided with the kit, and have difficulty spreading it over the specimen placement area. Still others may find it difficult to open and close the cover of the housing with one hand while holding the specimen collection stick in the other hand.
- Accordingly, it would be advantageous to provide an apparatus for testing for occult blood, for example, fecal occult blood, with features that enhance its ease of use by untrained individuals. Further, it would be advantageous to provide a hygienic and relatively simple test kit which reduces the need for manual dexterity, while providing accurate and reliable results.
- A self-contained system for testing for the presence of occult blood in a specimen has been provided with features enhancing its ease of use. The system includes a housing holding a test matrix and a container for releasing a developing medium onto the test matrix. The housing includes a base portion encasing both the container and the test matrix, and a moveable cover for selectively covering and uncovering the base. The cover is provided with a tab which can be manipulated with a finger of one hand, and the base is provided with tabs which can be grasped easily with one or two other fingers of the same hand, thus allowing the cover to be easily opened and closed with one hand.
- An applicator provided for use with the system includes a handle portion configured to be grasped by a user and a distal portion having an end configured for optimized retrieval and spreading of the specimen on the test matrix. In a preferred embodiment, the applicator comprises two identical applicator halves, one of which serves as the handle portion and the other of which serves as the distal portion. Connector elements are provided for joining the two halves together. For reasons of manufacturing convenience, the two halves are integrally formed with and frangibly connected to opposite sides of the system housing. To use the applicator, a user simply detaches the two applicator halves from the housing, assembles them end-to-end, then collects and applies the specimen as instructed.
- The instructions for use are preferably embossed or otherwise printed on the various components of the system. These instructions preferably indicate both the order in which the steps of the testing procedure are to be performed, and the location for carrying out the steps. Thus, steps to be performed with the cover closed are provided on the cover, steps to be performed with the cover open are provided on the top portion of the base, and steps to be performed with the housing inverted (and the cover closed) are provided on the bottom portion of the base. This reduces the chance of any confusion on the part of the user, and increases the likelihood that the test will be performed correctly and accurate results obtained.
- Each and every feature and combination of two or more features described herein is included within the scope of the present invention provided that the features included in the combination are not mutually inconsistent.
- These and other aspects and advantages of the present invention are set forth in the following detailed description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.
-
FIG. 1 is a perspective view of a system for testing for fecal occult blood in accordance with the present invention, with a portion broken away to show interior detail; -
FIG. 2 is a plan view of the housing, cover, and applicator of the system before assembly; -
FIG. 2A is an enlarged end view of the bottom section of the housing before assembly; -
FIG. 3 is a plan view of the system after assembly; -
FIG. 4 is an enlarged fragmentary perspective view showing a portion of the base of the system housing, with a portion broken away to show interior detail; -
FIG. 5 is a perspective view of an applicator assembly in accordance with the present invention; -
FIG. 6 is an enlarged plan view of the encircled area 6-6 ofFIG. 5 ; -
FIG. 7 is a plan view of the encircled area 7-7 ofFIG. 5 ; -
FIG. 8 is an enlarged, fragmentary view of a section taken through line 8-8 ofFIG. 1 ; -
FIG. 9 is an enlarged end view ofFIG. 7 ; -
FIG. 10 is a top plan view of the housing of the system according to a preferred embodiment, with the cover in a closed position; -
FIG. 11 is a perspective view of the housing according to the embodiment shown inFIG. 10 , with the cover in an open position; and -
FIG. 12 is a bottom plan view of the housing according to the embodiment ofFIG. 10 . - Referring now to the drawings,
FIG. 1 shows a self-containedsystem 10 for testing for a reactant such as occult blood in a specimen of a spreadable substance such as fecal matter (not shown). The system comprises ahousing 12 enclosing atest matrix 14 such as guaiac-treated paper (shown inFIG. 4 ), and aglass ampule 16 filled with a free-standing liquid developing medium such as liquid hydrogen peroxide/ethyl alcohol solution. Anapplicator 18 is provided for collecting the fecal matter specimen and applying it to aspecimen placement area 20 on thetest matrix 14. - Referring now to
FIG. 2 , the unassembled housing, which is preferably provided to the consumer in a hermetically sealed foil pouch (not shown), includes abase 22 and acover 24. Thebase 22 has abottom section 26 and atop section 28. Identical applicator halves 30 and 32 are coupled to opposite sides of thetop section 28 of thebase 22. In a preferred embodiment of the invention, thecover 24,bottom section 26,top section 28, andapplicator halves cover 24,bottom base section 26, andtop base section 28 are preferably flexibly and serially joined to one another by thinnedhinge elements top section 28 of the base 22 by weakenedelements -
FIG. 3 shows thesystem 10 in the form in which it is provided to the user. The test matrix and ampule have been placed underneath thetop section 28 of thebase 22, and thebottom section 26 has been folded up against thetop section 28, locking the test matrix and ampule into position. Thecover 24 has been latched over the specimen placement openings to prevent contamination of the test matrix during transport. The only portion of thesystem 10 which has not been preassembled is theapplicator 18. - Returning now to
FIG. 2 with additional reference toFIG. 12 , thebottom section 26 of thebase 22 has twooblong openings first end 46. The oblong openings have bevelededges 48 for better viewing of thevalidation areas 50 of thetest matrix 14. Tworectangular openings second end 56 of thebottom section 26. Therectangular openings edges 58 for better viewing of theresult areas 60 of thetest matrix 14. Acircular depression 62 is located in thesecond surface 51 intermediate the validationarea viewing openings area viewing openings protuberance 64 is located in the center of thedepression 62. Thedepression 62 decreases the rigidity of thebottom section 26 and enables a user to compress the ampule when theprotuberance 64 is pressed against a hard, flat surface such as a table or counter top. - It has been found that a
depression 62 formed in thesecond surface 51 of thebottom section 26 reduces the amount of liquid needed to saturate the matrix relative to the amount that would be needed if the depression were formed in thefirst surface 49. -
FIG. 2A is an enlarged end view showing that thebottom section 26 of the base is slightly curved about a vertical axis of symmetry y. Specifically, thebottom section 26 has generally flatside edge portions first surface 49 and asecond surface 51, both of which are somewhat concave with respect to the illustrated horizontal axis x. When thebottom section 26 is folded about thefront hinge 36 and snapped into place underneath thetop section 28, the curvature is flattened with respect to the horizontal axis x. Thus, thefirst surface 49 is urged against the center of the top section, compressing the test matrix and holding it securely in place. This minimizes the amount of open space between the top andbottom sections - The
top section 28 of thebase 22, best shown inFIG. 11 , includes tworectangular openings specimen placement areas 70 on thetext matrix 14, on the opposite side from theresult areas 60 and resultviewing openings dome 74 extends between thespecimen placement openings top section 28 near therear hinge 34. Extending from the inner top wall of thedome 74 are two projections (not shown) which act in tandem with thedepression 62 andprotuberance 64 on thebottom section 26 to facilitate breaking of theampule 16. - The
front hinge 36 projects distally along the front of thesection 28 and matingly receives ahook 75 depending from the underside of thecover 24 to latch the cover when necessary. A grippingarrangement comprising tabs FIG. 10 ) is provided for allowing a user to easily open and close thecover 24 with one hand while holding an applicator in the other hand. Specifically, thetabs top section 28 on either side of thehinge 36, are structured for a user to hold between two fingers, for instance the thumb and middle finger, of one hand while pressing upwardly with another finger, for instance the index finger, of the same hand against thetab 81 extending distally from the front edge of thecover 24. Strictly speaking, only onetab top section 28 of the base, since most users will be able to open thecover 24 using only the thumb and finger of one hand. However, twotabs - Referring again to
FIG. 3 , with additional reference toFIGS. 5 and 6 , each of the applicator halves 30, 32 comprises a relatively narrowdistal end 76 a,b and a wider, hollowproximal end 78 a,b. To assemble theapplicator 10, the user simply detaches the twoapplicator halves base 28, and inserts thedistal end 76 b of oneapplicator half 32 into the hollowproximal end 78 a of theother applicator half 30. A close fit between thedistal end 76 b of oneapplicator half 32 and the receivingproximal end 78 a of theother applicator half 30 ensures that thehalves - When the applicator halves 30, 32 are assembled, the proximally positioned
half 32 serves as a handle to be grasped by the user, while thedistal end 76 a of the distally positionedhalf 30 serves as a collector and spreader. - Referring now to
FIGS. 7-9 , the spreader ordistal end 76 a of theapplicator 18 includes a generally planarfront surface 80, a generally planar rear surface (not shown) and a pair ofside walls side walls shoulder 86 that curves about a center of curvature x′ to define a first radius of curvature R.A spreading tip 88 extends distally of theshoulder 86. - The features of the spreading
tip 88 can best be appreciated after considering the design of the specimen placement openings, as shown in detail inFIGS. 4 and 8 . Specifically, thespecimen placement openings trapezoidal walls 72 that assist in positioning specimens on thespecimen placement area 70 and define a recess with enough volume to receive and hold a fecal sample when thecover 24 is closed. Each recess has a width w equal to the width of the specimen placement area and a depth d equal to the height of thebeveled walls 72. The spreadingtip 88 includes a pair of side edges 92, 93 which are preferably conical and have a cone angle conforming to thebeveled side walls 72 of thespecimen placement openings distal surface 90 is substantially equal to the width w of thespecimen placement openings tip 88 is slightly less than the depth d of thespecimen placement openings tip 88 and thespecimen placement openings - In addition, the spreading tip has a curved
distal surface 90 that extends between the side edges 92, 93. Thedistal surface 90 defines a second radius of curvature r=R+L about the center of curvature x′. Because the spreadingtip 88 and the end portion 85 of the applicator have the same center of curvature x′, a user is able to maintain a constant distance from the center x′ to the test matrix while applying the samples, regardless of moderate changes of the angle at which theapplicator 18 is tilted with respect to the test matrix. This results in a constant clearance c between thedistal surface 90 of the applicator and thetest matrix 14, allowing the user to easily apply the specimen in a layer of fairly uniform thickness. - The distal and
proximal surfaces tip 88 are preferably textured or otherwise enhanced to increase the amount of fecal matter collected by theapplicator 18 and minimize the likelihood of any fecal matter falling off. In the illustrated embodiment, best seen inFIG. 9 , thetextured surface 90 comprises a multitude of small bumps yielding a sandpaper-like finish. Other surface features, such as grooves, fins, dimples or the like, that increase the effective surface area and holding power of the tip can also be used. Alternatively, the retentiveness of the surface could be enhanced with coatings having adhesive properties or an affinity for fecal matter. -
FIGS. 10-12 show an especially preferred embodiment of the invention, wherein the various components of thehousing 12 include indicia leading the user through the steps of a testing procedure. The indicia are preferably provided in sets, with each set of indicia designating both the order in which a particular step is to be performed, and the place for performing it. For instance, a first set ofindicia 94 provided near the distal end of thecover 24 of thehousing 12 may point toward thetab 81 and instruct the user to “LIFT FIRST .” Upon lifting the cover, the user may find a second set ofindicia 95 near thespecimen placement openings SAMPLES 2nd.” A third set ofindicia 96 located on thecover 24 on anupper dome 97 above the ampule-holdingdome 74 may instruct the user to “PRESS indicia 98 on thebottom section 26 of thehousing base 22 identifies the location of the “CONTROLS ” and “RESULTS ” and instructs the user that these are to be viewed “4th.” - For optimum readability, it is preferred that the indicia be embossed on the housing. However, imprinted stickers or other less permanent forms of indicia may be preferable in some instances, especially in overseas markets where many languages will be required. Additional indicia could be provided for designating where to snap the applicator halves off the housing, indicating which end of the applicator is the sample end, warning the user not to open the base because of glass inside, and so forth. Of course, the exact wording of any of the instructions is not critical, and may be varied according to consumer needs.
- The indicia may also provide information such as a website, mailing address, or phone number which the user may contact if he or she has questions about the procedure or results. If the results are positive or indeterminate, the user may wish to save another undeveloped test kit to show to a physician. Ideally, if the results are clearly negative, the user simply reinserts the kit and applicator halves into the foil pouch in which they were provided, folds over the top of the pouch, and throws it away. No further special handling or sanitary precautions are needed since the fecal matter is entirely enclosed.
- While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims. For instance, the ease of use features disclosed can successfully be used with fecal blood testing kits employing polyclonal or monoclonal antibody systems, or any other alternatives to the guaiac-based chemistry system disclosed in International Patent Application No. PCT/US99/17594. The features may also be used in both chemical and non-chemical systems for revealing the presence of a wider variety of anomalous substances other than blood, such as parasites, for instance, in feces or other spreadable specimens.
Claims (29)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/654,067 US20070116593A1 (en) | 2002-05-03 | 2007-01-16 | Occult blood testing apparatus with features for enhancing ease of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/139,473 US7189356B1 (en) | 2002-05-03 | 2002-05-03 | Occult blood testing apparatus with features for enhancing ease of use |
US11/654,067 US20070116593A1 (en) | 2002-05-03 | 2007-01-16 | Occult blood testing apparatus with features for enhancing ease of use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/139,473 Division US7189356B1 (en) | 2002-05-03 | 2002-05-03 | Occult blood testing apparatus with features for enhancing ease of use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070116593A1 true US20070116593A1 (en) | 2007-05-24 |
Family
ID=37833358
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/139,473 Expired - Fee Related US7189356B1 (en) | 2002-05-03 | 2002-05-03 | Occult blood testing apparatus with features for enhancing ease of use |
US11/654,067 Abandoned US20070116593A1 (en) | 2002-05-03 | 2007-01-16 | Occult blood testing apparatus with features for enhancing ease of use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/139,473 Expired - Fee Related US7189356B1 (en) | 2002-05-03 | 2002-05-03 | Occult blood testing apparatus with features for enhancing ease of use |
Country Status (1)
Country | Link |
---|---|
US (2) | US7189356B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080131971A1 (en) * | 2006-09-25 | 2008-06-05 | Diagnostica, Inc. | Occult blood testing device |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7488450B2 (en) * | 2004-03-04 | 2009-02-10 | Beckman Coulter, Inc. | Analyte collection and detection devices |
USD598121S1 (en) | 2004-07-22 | 2009-08-11 | Lastella Vincent | Sampling device |
US8679420B2 (en) * | 2004-07-22 | 2014-03-25 | Immunostics, Inc. | Fecal sampling device and method |
USD596753S1 (en) * | 2004-07-22 | 2009-07-21 | Lastella Vincent P | Testing device |
US20080241940A1 (en) * | 2004-07-22 | 2008-10-02 | Lastella Vincent P | Fecal sampling device and method |
US7556769B2 (en) * | 2006-11-10 | 2009-07-07 | Kevin Kikta | Fecal occult test packaging |
US8304596B2 (en) | 2008-04-11 | 2012-11-06 | Immunostics, Inc. | Fecal sampling device and method |
Citations (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US281903A (en) * | 1883-07-24 | James mckenzie | ||
US4071317A (en) * | 1977-03-14 | 1978-01-31 | Miles Laboratories, Inc. | Test composition and device for determining peroxidatively active substances and process for preparing same |
US4337734A (en) * | 1979-09-27 | 1982-07-06 | Yamaha Hatsudoki Kabushiki Kaisha | Two-cycle engine |
US4365970A (en) * | 1981-05-01 | 1982-12-28 | Smithkline Instruments, Inc. | Specimen test slide and method for testing occult blood |
US4382064A (en) * | 1981-01-29 | 1983-05-03 | Smithkline Instruments, Inc. | Specimen slide for occult blood testing |
US4562043A (en) * | 1983-09-09 | 1985-12-31 | Mennen Frederick C | Self-contained swab cartridge apparatus for detecting occult blood |
US4582685A (en) * | 1982-10-07 | 1986-04-15 | Helena Laboratories Corporation | Test kit for performing a medical test |
US4615982A (en) * | 1984-12-11 | 1986-10-07 | Lawrence Paul J | Fecal occult blood test |
US4645743A (en) * | 1986-03-11 | 1987-02-24 | Smithkline Diagnostics, Inc. | Method and device for collecting and testing for fecal occult blood |
US4738823A (en) * | 1985-08-30 | 1988-04-19 | Miles Laboratories, Inc. | Test strip with adjustable sample absorption capacity |
US4789629A (en) * | 1986-11-24 | 1988-12-06 | Smithkline Beckman Corporation | Method and device for collecting and testing for fecal occult blood |
US4818702A (en) * | 1986-06-02 | 1989-04-04 | Litmus Concepts, Inc. | Fecal occult blood test reagent |
US4937197A (en) * | 1984-12-11 | 1990-06-26 | Litmus Concepts, Inc. | Fecal occult blood test method |
US4939097A (en) * | 1986-06-02 | 1990-07-03 | Litmus Concepts, Inc. | Fecal occult blood test methods |
US4983416A (en) * | 1985-02-04 | 1991-01-08 | Propper Manufacturing Co., Inc. | Manufacturing method for an occult fecal blood test slide |
US5100619A (en) * | 1989-05-09 | 1992-03-31 | Beckman Instruments, Inc. | Device and method for collecting fecal occult blood specimens |
US5106582A (en) * | 1990-12-18 | 1992-04-21 | Smithkline Diagnostics, Inc. | Specimen test slide and method of testing for fecal occult blood |
US5137808A (en) * | 1987-04-07 | 1992-08-11 | Syntex (U.S.A.) Inc. | Immunoassay device |
US5171629A (en) * | 1989-01-17 | 1992-12-15 | Hoechst Aktiengesellschaft | Flame-resistant carrier web for bitumen webs and a process for its production |
US5182191A (en) * | 1988-10-14 | 1993-01-26 | Pacific Biotech, Inc. | Occult blood sampling device and assay |
US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5198365A (en) * | 1987-02-04 | 1993-03-30 | International Immunoassay Laboratories, Inc. | Fecal sample immunoassay method testing for hemoglobin |
US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5254181A (en) * | 1989-06-10 | 1993-10-19 | Daidousanso Co., Ltd. | Method of nitriding steel utilizing fluoriding |
US5310680A (en) * | 1987-09-16 | 1994-05-10 | Smithkline Diagnostics, Inc. | Test for fecal occult blood |
US5344762A (en) * | 1992-03-29 | 1994-09-06 | Era-Masis, Ltd. | Method for the early diagnosis of cancer |
US5391498A (en) * | 1987-09-16 | 1995-02-21 | Smithkline Diagnostics, Inc. | Test for fecal occult blood |
US5504013A (en) * | 1993-11-12 | 1996-04-02 | Unipath Limited | Analytical devices and methods of use thereof |
US5593851A (en) * | 1994-04-01 | 1997-01-14 | Chek-Med Systems, Inc. | Test kid for the rapid detection of helicobacter pylori in gastric biopsy tissue |
US5747351A (en) * | 1995-06-07 | 1998-05-05 | Smithkline Diagnostics, Inc. | Immunochemical-based test device with lift and twist specimen full tab |
US5840584A (en) * | 1995-06-07 | 1998-11-24 | Waldenburg; Ottfried | Blood in feces test device |
US6077711A (en) * | 1998-02-25 | 2000-06-20 | Singer; Jason | Frangible ampule specimen test card |
US6436714B1 (en) * | 1998-08-11 | 2002-08-20 | Diagnostica, Inc. | Self-contained system and method for testing for fecal occult blood |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4333734A (en) | 1980-01-18 | 1982-06-08 | Sloan-Kettering Institute For Cancer Research | Diagnostic device for fecal occult blood and method of use |
USD281903S (en) | 1983-02-09 | 1985-12-24 | C. B. Fleet Company, Inc. | Fecal occult blood test kit |
US5171529A (en) | 1992-01-24 | 1992-12-15 | Robert Schreiber | Occult blood testing device |
US5264181A (en) | 1992-01-24 | 1993-11-23 | Robert Schreiber | Occult blood testing device |
CA2337693A1 (en) | 1998-08-04 | 2000-02-17 | Cor Therapeutics, Inc. | Transgenic animals having a modified glycoprotein v gene |
-
2002
- 2002-05-03 US US10/139,473 patent/US7189356B1/en not_active Expired - Fee Related
-
2007
- 2007-01-16 US US11/654,067 patent/US20070116593A1/en not_active Abandoned
Patent Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US281903A (en) * | 1883-07-24 | James mckenzie | ||
US4071317A (en) * | 1977-03-14 | 1978-01-31 | Miles Laboratories, Inc. | Test composition and device for determining peroxidatively active substances and process for preparing same |
US4337734A (en) * | 1979-09-27 | 1982-07-06 | Yamaha Hatsudoki Kabushiki Kaisha | Two-cycle engine |
US4382064A (en) * | 1981-01-29 | 1983-05-03 | Smithkline Instruments, Inc. | Specimen slide for occult blood testing |
US4365970A (en) * | 1981-05-01 | 1982-12-28 | Smithkline Instruments, Inc. | Specimen test slide and method for testing occult blood |
US4582685A (en) * | 1982-10-07 | 1986-04-15 | Helena Laboratories Corporation | Test kit for performing a medical test |
US4562043A (en) * | 1983-09-09 | 1985-12-31 | Mennen Frederick C | Self-contained swab cartridge apparatus for detecting occult blood |
US4937197A (en) * | 1984-12-11 | 1990-06-26 | Litmus Concepts, Inc. | Fecal occult blood test method |
US4615982A (en) * | 1984-12-11 | 1986-10-07 | Lawrence Paul J | Fecal occult blood test |
US4983416A (en) * | 1985-02-04 | 1991-01-08 | Propper Manufacturing Co., Inc. | Manufacturing method for an occult fecal blood test slide |
US4738823A (en) * | 1985-08-30 | 1988-04-19 | Miles Laboratories, Inc. | Test strip with adjustable sample absorption capacity |
US4645743A (en) * | 1986-03-11 | 1987-02-24 | Smithkline Diagnostics, Inc. | Method and device for collecting and testing for fecal occult blood |
US4818702A (en) * | 1986-06-02 | 1989-04-04 | Litmus Concepts, Inc. | Fecal occult blood test reagent |
US4939097A (en) * | 1986-06-02 | 1990-07-03 | Litmus Concepts, Inc. | Fecal occult blood test methods |
US4789629A (en) * | 1986-11-24 | 1988-12-06 | Smithkline Beckman Corporation | Method and device for collecting and testing for fecal occult blood |
US5198365A (en) * | 1987-02-04 | 1993-03-30 | International Immunoassay Laboratories, Inc. | Fecal sample immunoassay method testing for hemoglobin |
US5137808A (en) * | 1987-04-07 | 1992-08-11 | Syntex (U.S.A.) Inc. | Immunoassay device |
US5310680A (en) * | 1987-09-16 | 1994-05-10 | Smithkline Diagnostics, Inc. | Test for fecal occult blood |
US5391498A (en) * | 1987-09-16 | 1995-02-21 | Smithkline Diagnostics, Inc. | Test for fecal occult blood |
US5182191A (en) * | 1988-10-14 | 1993-01-26 | Pacific Biotech, Inc. | Occult blood sampling device and assay |
US5171629A (en) * | 1989-01-17 | 1992-12-15 | Hoechst Aktiengesellschaft | Flame-resistant carrier web for bitumen webs and a process for its production |
US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5100619A (en) * | 1989-05-09 | 1992-03-31 | Beckman Instruments, Inc. | Device and method for collecting fecal occult blood specimens |
US5254181A (en) * | 1989-06-10 | 1993-10-19 | Daidousanso Co., Ltd. | Method of nitriding steel utilizing fluoriding |
US5106582A (en) * | 1990-12-18 | 1992-04-21 | Smithkline Diagnostics, Inc. | Specimen test slide and method of testing for fecal occult blood |
US5344762A (en) * | 1992-03-29 | 1994-09-06 | Era-Masis, Ltd. | Method for the early diagnosis of cancer |
US5504013B1 (en) * | 1993-11-12 | 2000-03-14 | Unipath Ltd | Analytical devices and methods of use thereof |
US5504013A (en) * | 1993-11-12 | 1996-04-02 | Unipath Limited | Analytical devices and methods of use thereof |
US5593851A (en) * | 1994-04-01 | 1997-01-14 | Chek-Med Systems, Inc. | Test kid for the rapid detection of helicobacter pylori in gastric biopsy tissue |
US5668011A (en) * | 1994-04-01 | 1997-09-16 | Chek-Med Systems, Inc. | Molded pick for handling biopsy specimens |
US5747351A (en) * | 1995-06-07 | 1998-05-05 | Smithkline Diagnostics, Inc. | Immunochemical-based test device with lift and twist specimen full tab |
US5840584A (en) * | 1995-06-07 | 1998-11-24 | Waldenburg; Ottfried | Blood in feces test device |
US6077711A (en) * | 1998-02-25 | 2000-06-20 | Singer; Jason | Frangible ampule specimen test card |
US6436714B1 (en) * | 1998-08-11 | 2002-08-20 | Diagnostica, Inc. | Self-contained system and method for testing for fecal occult blood |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080131971A1 (en) * | 2006-09-25 | 2008-06-05 | Diagnostica, Inc. | Occult blood testing device |
WO2008039384A3 (en) * | 2006-09-25 | 2009-02-12 | Diagnostica Inc | Occult blood testing device |
US7592181B2 (en) * | 2006-09-25 | 2009-09-22 | Diagnostica, Inc. | Occult blood testing device |
Also Published As
Publication number | Publication date |
---|---|
US7189356B1 (en) | 2007-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070116593A1 (en) | Occult blood testing apparatus with features for enhancing ease of use | |
US4259964A (en) | Device for obtaining stool samples | |
JP3964009B2 (en) | Remote dose type analyte concentration meter | |
US7927562B2 (en) | Collection and assay device for biological fluid | |
US7294502B2 (en) | Device for collecting liquid samples | |
US11358139B2 (en) | Pinch to open sample collection device | |
US8025851B2 (en) | Specimen sample collection device and test system | |
JP4667389B2 (en) | Sample collection cup with integrated sample analysis system | |
US5380492A (en) | Sampling device and sample adequacy system | |
US20050227372A1 (en) | Diagnostic test kit | |
US7618591B2 (en) | Specimen sample collection device and test system | |
US4367750A (en) | Device for obtaining stool samples | |
EP0503379B1 (en) | Test device sample delivery means | |
JP2007511767A (en) | High-speed sample analysis and storage device and method of use | |
JPH11506201A (en) | An immunochemistry-based test device with a lifting and twisting sample tension tab | |
US5342330A (en) | Assemblies for collecting urine and other body fluids | |
US7592181B2 (en) | Occult blood testing device | |
AU635790B2 (en) | Easy handling reagent strip | |
AU2009341554B2 (en) | Collection and assay device for biological fluid | |
JPH07213924A (en) | Test apparatus | |
US20050025670A1 (en) | Diagnostic device and method of using same | |
CN221281046U (en) | Sample collection and detection device | |
KR102445175B1 (en) | Diagnostic kit for specimen transport container capable of self-inspection | |
JP2884126B2 (en) | Urine collection container | |
US20040052684A1 (en) | Diagnostic kit and method of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DIAGNOSTICA CORPORATION, NEVADA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME FROM DIAGNOSTICA, INC. TO DIAGNOSTICA CORPORATION PREVIOUSLY RECORDED ON REEL 012878 FRAME 0329. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:CLAWSON, BURRELL E.;REEL/FRAME:027119/0691 Effective date: 20020503 |
|
AS | Assignment |
Owner name: CLAWSON, BURRELL E., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAGNOSTICA CORPORATION;REEL/FRAME:027390/0895 Effective date: 20111208 Owner name: MOSS, STEVEN, RHODE ISLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAGNOSTICA CORPORATION;REEL/FRAME:027390/0895 Effective date: 20111208 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |